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Abstract
Utilizing RNA interference technology with siRNA in the HD11 macrophage cell line, we determined how the inhibition or
knock-down of the iNOS (inducible nitric oxide synthase) gene affected IFN-g-induced macrophage production of nitric oxide
(NO) and mRNA expression of genes involved in this biological pathway in the chicken. Chicken macrophages produce NO when
stimulated with recombinant chicken IFN-g, however, when transfected with iNOS siRNAs, the production of NO is significantly
decreased. We observed a 14–28% reduction in NO production by IFN-g-stimulated HD11 cells at 48 h after initial siRNA
transfection compared to non-transfected IFN-g-stimulated macrophages. Significant knock-down of iNOS mRNA expression (15
to 50-fold lower) was observed for each of four iNOS siRNAs, when compared to non-transfected IFN-g-stimulated macrophages
and to those treated with a negative control siRNA. The IFN-g-stimulated chicken macrophages transfected with iNOS siRNAs did
not show altered levels of mRNA expression for genes involved in IFN-g signaling and iNOS pathways (IL-1b, IL-6, IFN-g, TGF-
b4, or SOCS-3) suggesting that the observed decrease in NO production is a direct result of siRNAmediated knock-down of iNOS,
rather than IFN-g-induced changes in the other genes tested.
# 2008 Elsevier B.V. All rights reserved.
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1. Introduction
RNA interference or RNAi is a powerful tool to
examine the function of specific genes and their
potential role(s) in biological pathways (McManus
and Sharp, 2002; Tuschl, 2001). When used to knock-
down or silence a target gene of interest, the resulting
loss of function can illuminate intricate gene interac-
tions involved in fundamental biological processes such
as growth and development, reproduction, cellular
homeostasis, and immune responses. RNAi technology
is an especially powerful tool for studying deleterious or
lethal knock-out genes or for experiments with animal
species not readily manipulated with current transgenic
or knock-out procedures, such as the chicken.
RNA interference has been utilized in numerous
studies investigating the role of specific gene(s) in
biological pathways and disease processes including
many related to immune function. Using RNA
interference, TLR2 and TLR3 molecules were shown
to be involved in IFN-g-stimulated macrophage
recognition of Leishmania donovani (Flandin et al.,
2006). Silencing of IL-10 in human dendritic cells
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promoted Th1 responses in naı¨ve CD4 T-cells via
production of IL-12 and IFN-g while decreasing IL-4
cytokine production (Liu et al., 2004). Inhibition of the
chemokine receptor, CCR5, induced IL-6 and IL-8
protein production and blocked replication of HIV in a
CD4 T-cell line (Pauls et al., 2006). RNA interference of
viral replication, developmentally controlled genes, and
myostatin in avian cells has also been demonstrated
(Chen et al., 2007; Dai et al., 2005; Sato et al., 2006).
Inducible nitric oxide synthase (iNOS), also known
as NOS-2, is an enzyme that produces nitric oxide (NO)
from the amino acid L-arginine (Bogdan, 2001; Bogdan
et al., 2000; Alderton et al., 2001). Produced by
macrophages stimulated with cytokine and/or microbial
components, NO plays a powerful role in immune
responses due to its antimicrobial and anti-tumor
functions (Bogdan, 2001; Blanchette et al., 2003;
Bogdan et al., 2000; MacMicking et al., 1997). iNOS
activity is primarily regulated at the transcriptional
level, although translational and posttranslational
events such as protein dimerization and stability along
with phosphorylation have been shown to influence
iNOS activity (Aktan, 2004; Kleinert et al., 2004).
The activation of transcription factors such as NF-kb
by LPS, TNF-a, and IL-1b induces iNOS expression
and NO production in macrophages (Aktan, 2004;
Kleinert et al., 2004). Additional cytokines and cellular
signaling molecules have been implicated in the
regulation and induction of iNOS-mediated NO
production (Bogdan, 2001). Stimulation of murine,
rat, and human macrophages with LPS, IFN-g, IL-6, IL-
1b, TNF-a, or a combination of these molecules
induces iNOS expression (Kleinert et al., 2003, 2004).
Interleukin-6 and IFN-g activate members of the Jak/
Stat pathway of intracellular signaling and transcription
factors, namely Jak1 and Jak2, and Stat1 and Stat5
(Paukku and Silvennoinen, 2004; Schindler and
Bogdan, 2001). Suppressor of cytokine signaling-3
(SOCS-3), intimately associated with Jak1, is induced
by various cytokines such as IL-1, IL-6, IFN-g, and
TNF-a and inhibits the signaling of IL-6 and IFN-g and
other cytokine signaling pathways as well (Paukku and
Silvennoinen, 2004; Tan and Rabkin, 2005). Trans-
forming growth factor-b1 (TGF-b1) negatively reg-
ulates iNOS expression and NO production at many
levels and is considered the most important negative
regulator of iNOS-mediated NO production in macro-
phages (Vodovotz, 1997; Vodovotz et al., 1999).
Murine (Blanchette et al., 2003) and human
macrophages (Bogdan, 2001) stimulated with IFN-g
produce high levels of NO. The production of NO by
IFN-g-stimulated chicken macrophages and monocytes
have also been established (Okamura et al., 2005;
Withanage et al., 2005; Crippen et al., 2003; Su and
Austic, 1998; Chang et al., 1996; Sung et al., 1991). In a
similar manner as IFN-g, LPS has been shown to induce
NO production in chicken macrophages (Hussain and
Qureshi, 1997; Dil and Qureshi, 2003). Increased NO
production by chicken macrophages infected with
various Salmonella and Eimeria species indicates a
role of NO and, therefore, likely iNOS activity, in avian
immunity to disease (Babu et al., 2006; Lillehoj and Li,
2004). Using siRNAmethodology, we investigated how
knock-down of the iNOS gene would alter NO
production in the chicken macrophage line, HD11,
and the effects on mRNA expression of several genes in
IFN-g-iNOS-NO pathways.
2. Materials and methods
2.1. Macrophage culture, transfection, and IFN-g
stimulation
The chicken macrophage cell line, HD11 (Beug
et al., 1979), was maintained in RPMI 1640 medium
(Sigma) supplemented with 10% newborn calf serum
(heat-inactivated), 10 mM HEPES, 2 mM glutamine,
1 mM sodium pyruvate, 0.1 mM non-essential amino
acids, 100 U/ml penicillin, 100 mg/ml streptomycin,
and 5  105 M 2-mercaptoethanol (pH 7.3) at 41 8C
and 5% CO2. Cells were cultured in 75 cm
2 tissue
flasks (Corning Inc., Corning, NY) and split approxi-
mately every 3 days. HD11 macrophages
(1  105 cells in 200 ml media) were cultured over-
night in sterile 96 well plates. Prior to transfection, the
RPMI 1640 media was gently aspirated from the wells
and cells were rinsed with 100 ml Opti MEM(R) I
reduced-serum medium (Gibco Invitrogen, Carlsbad,
CA) to remove any residual RPMI 1640 medium.
siPORT NeoFX (Ambion, Austin, TX) transfection
reagent was used according to manufacturer’s instruc-
tions to deliver a 100 nM concentration of siRNA in a
final volume of 100 ml. As measured by flow
cytometry using Silencer FAM GAPDH siRNA
(Ambion, Austin, TX), transfection efficiency aver-
aged 30–35%. Cells not treated with siRNA were
incubated in a similar manner with 100 ml Opti
MEM(R) I reduced-serum medium alone. After 4 h of
incubation at 41 8C and 5% CO2, all medium was
removed and cells were rinsed with 100 ml Opti
MEM(R) I reduced-serum medium. 200 ml of RPMI
1640 supplemented as above and with recombinant
chicken IFN-g expressed in COS cells (Song et al.,
1997) at a dilution of 1:25 was added to each
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individual well and cultured for 48 h at 41 8C and 5%
CO2. After 48 h of IFN-g stimulation, assay plates
were frozen at 20 8C until thawed for RNA isolation
and quantification of NO production. Untreated HD11
cells were stimulated with recombinant chicken IFN-g
were given 200 ml of RPMI 1640 plus supplements
alone and incubated under identical conditions. A total
of four replicate experiments, each consisting of six
identical wells per each of 8 treatments (unstimulated
and untransfected with siRNA, IFN-g-stimulated and
untransfected with siRNA, stimulated and transfected
with siRNA #1, 2, 3, 4, or a non-sense negative
control, and stimulated and treated with a combination
of siRNA #1, 2, 3, and 4) were performed.
2.2. iNOS siRNA construction and sequence
Four siRNA targeted towards different regions of the
chicken iNOS mRNA sequence (GenBank Accession #
MN 204961) and one non-sense negative control were
designed with siRNATarget Finder software (Ambion,
Austin, TX) and were custom synthesized and HPLC
purified by Ambion. The iNOS siRNA sequences used
are as follows:
siRNA #1 50 GUGUGGAGUUCACAAAGUUtt 30
siRNA #2 50 GAUUCUGUGCAUGGAUGAGtt 30
siRNA #3 50 UUCCCAUGAAGCUGAAAUUtt 30
siRNA #4 50 GCCGUGCAUUCUUAUUGGCtt 30
siRNA neg. 50 CUUGAUGACUAUAGAUGCGtt 30
The non-sense negative control siRNA sequence has
a similar percentage of each nucleotide as represented
in the four iNOS siRNAs and shows no homology to the
chicken genome (Ensembl release 48, December 2007,
www.ensembl.org/Gallus_gallus/index.html).
2.3. Quantification of nitric oxide
Thawed aliquots of 50 ml culture supernatants mixed
with 50 ml Griess reagent: 5% phosphoric acid (Fisher
Scientific, Fair Lawn, NJ), 1% sulfanilamide and 0.1%
N-naphthylethylenediamine (Sigma Aldrich, St. Louis,
MO) were incubated at room temperature for approxi-
mately 10 min and then were read on an ELISA
Microplate plate reader (Bio-Rad, Hercules, CA) at
570 nm (Green et al., 1982). A standard curve produced
from 0 to 50 nmoles of NaNO2 was prepared for
calculation of NO production in test samples.
2.4. RNA isolation and gene expression
Total RNA was isolated from pooled samples (6
individual wells per treatment, 4 replicates per each
treatment performed on different days) using RNAq-
uous# (Ambion, Austin, TX) according to manufac-
turer’s instructions. Gene expression levels of mRNA
transcripts were analyzed by quantitative real-time RT-
PCR using QuantiTect SYBR Green RT-PCR (Qiagen,
Waltham, MA) as previously reported (Cheeseman
et al., 2007). Primer sequences for 28S, IL-1b, IL-6,
IFN-g, and TGF-b4 have been previously reported and
do not amplify genomic DNA as they span an intron–
exon boundary (Kogut et al., 2003). Because the
primers for iNOS (Xing and Schat, 2000) have been
reported to amplify both RNA and genomic DNA,
samples were DNase treated with DNA-Free (Ambion,
Austin, TX) according to manufacturer’s instructions
before amplification. Chicken TGF-b4 is generally
recognized as the avian counterpart of mammalian
TGF-b1, having similar functions in immunity in birds
(Jakowlew et al., 1997). The SOCS-3 primer sequences
are as follows:
Forward 50 GCCCCAGGTGATGGTGTA 30
Reverse 50 CTTAGAGCTGAACGTCTTGAGG 30
Quantitative real-time RT-PCR reactions, run in
triplicate for each sample and gene, were performed
as previously described (Cheeseman et al., 2007).
Briefly, the q-RT-PCR reactions were performed on
an Opticon 2 (Bio-Rad, Hercules, CA) with the
following program: 1 cycle at 50 8C for 30 min, 95 8C
for 15 min followed by 45 cycles of 94 8C for 15 s,
59 8C for 30 s, and 72 8C for 30 s followed by reading
of the plate. Additionally, a melting curve from 60 to
90 8C with a reading every 1 8C was generated on all
RT-PCR 96-well plates. Data were transformed and
expressed as the adjusted Ct (cycle threshold) value
using the following formula:
Slopes were determined with a series of 10-fold
dilutions of plasmids encoding each target
gene to determine PCR efficiency, and median 28S
Ct represents the median Ct value of all
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40 ðmean test gene CtÞ þ ðmedian 28SCtmean 28SCtÞ  test gene slope
28S slope
  
individual samples for this housekeeping reference
gene.
Additionally, for differentially expressed genes, the
fold change in mRNA expression of the untransfected
HD-11 cells compared to iNOS siRNA transfected cells
was calculated using the 2DDCT method (Livak and
Schmittgen, 2001).
2.5. Statistical analysis
Individual mRNA levels for each treatment and the
four replicates are analyzed as the mean of triplicate
well measurements. Analysis of gene mRNA expres-
sion and analyzed NO production levels was performed
with an ANOVA model using JMP software (JMP)
(SAS Institute, 2004).
3. Results and discussion
HD11 chicken macrophages produce nitric oxide
when stimulated with recombinant chicken IFN-g
(Lillehoj and Li, 2004). To determine the role of iNOS
expression in NO production in chicken macrophages,
HD11 cells were cultured with one of four iNOS
siRNAs, a combination of the four iNOS siRNAs, or a
non-sense (negative) siRNA, then stimulated with
chicken IFN-g. After 48 h of IFN-g stimulation, NO
was determined using the Griess assay. Using a standard
curve produced from 0 to 50 nmoles of NaNO2, we
determined the amount of NO (in mM) produced in
HD11 macrophages.
HD11 cells transfected with iNOS siRNAs and
stimulated with IFN-g produced significantly lower
levels of NO than those transfected with a non-sense
iNOS siRNA and stimulated with IFN-g, or HD11 cells
stimulated with IFN-g alone (Table 1). The non-sense
(negative) iNOS siRNA induced a modest but sig-
nificant decrease in NO production by the HD11
macrophages. Compared to IFN-g-stimulated macro-
phages, treatment with the non-sense siRNA resulted in
a reduction of only 4.5% while the other iNOS specific
siRNAs showed significantly lower levels of NO
production compared to the non-sense siRNA or no
siRNA transfected macrophages.
All iNOS siRNAs significantly decreased NO
production in the HD11 chicken macrophages to varied
degrees (Table 1). Macrophages treated with iNOS
siRNA #1 showed the largest decrease in NO production
(28.6%) compared to non-transfected IFN-g-stimulated
macrophages. The least reduction of NO production
was observed in siRNA #2 treated macrophages,
corresponding to a 14.5% reduction in NO production
compared to non-transfected IFN-g-stimulated chicken
macrophages.
Approximately 30% of macrophages were success-
fully transfected with iNOS siRNAs as assessed by flow
cytometry using a FAM labeled GAPDH siRNA
(Ambion, Austin TX). Therefore, the decreased NO
production observed (22%) at the whole culture level
was due to only the fraction of cells which exhibited the
effects of gene knock-down. Increasing the efficiency of
siRNA transfection in future experiments could abate
this ‘‘diluting’’ effect and demonstrate a more robust
interference of the iNOS gene.
To better verify that the IFN-g-iNOS-NO pathway
was directly affected by iNOS knock-down and not the
result of changes in expression of related genes, we
determined mRNA levels for several genes known to be
involved in IFN-g-induced iNOS biological pathways.
Transfection with iNOS siRNAs did not alter mRNA
expression levels for IFN-g, IL-1b, IL-6, TGF-b4, or
SOCS-3 in HD11 chicken macrophages (Fig. 1).
However, we observed a significant decrease or
‘‘knock-down’’ of iNOS mRNA expression in macro-
phages treated with all iNOS siRNAs compared to
HD11 cells stimulated with IFN-g alone (Fig. 1).
Transfection with iNOS siRNAs induced significantly
lower iNOS mRNA levels corresponding to 15 to 50-
J.H. Cheeseman et al. / Veterinary Immunology and Immunopathology 125 (2008) 375–380378
Table 1
Nitric oxide production in HD-11 chicken macrophages treated with IFN-g and siRNAs
Treatment OD 570 nm mM NaNO2
* % reduction compared to IFN-g alone
IFN-g 0.1032a 9.05 0
Neg. siRNA + IFN-g 0.0971b 8.64 4.5
siRNA #1 + IFN-g 0.0872d,e 6.46 28.62
siRNA #2 + IFN-g 0.0903c,d 7.74 14.49
siRNA #3 + IFN-g 0.0881c 7.43 17.91
siRNA #4 + IFN-g 0.0817f 6.52 27.97
siRNA #1–4 + IFN-g 0.0848e 6.96 23.13
OD readings not sharing a letter are significantly different by LS Means Student’s t-test (P < 0.05). A standard curve was used to calculate mM
concentration of NaNO2 (*) (mM NO = 142.06 (OD 570 nm)5.09).
fold less iNOS mRNA expression compared to
untreated HD11 cells (not shown). No difference in
iNOS mRNA expression was observed for HD11
macrophages treated with a non-sense or negative
siRNA compared to those stimulated with only IFN-g.
In this paper we report the usage of siRNAs to knock-
down gene expression in avian macrophages. Specifi-
cally, we demonstrate that HD11 chicken macrophages
when treated with iNOS siRNAs and stimulated with
recombinant chicken IFN-g produce significantly less
NO and have lower iNOS mRNA levels compared to
IFN-g-stimulated HD11 cells untreated with siRNAs.
No alterations in mRNA levels for several other genes
known to be involved in iNOS and IFN-g pathways such
as IFN-g, IL-1b, IL-6, TGF-b4, and SOCS-3 were
observed, suggesting that the lower NO production and
decreased iNOS mRNA presented in this study are the
direct result of siRNA-mediated inhibition of the iNOS
gene in chicken macrophages.
Recently, inhibition of the cytokine genes IL-10 and
IFN-g with siRNAs was reported in the pig (Sidahmed
andWilkie, 2007) demonstrating the feasibility of RNA
interference in studies involving agricultural animal
species. As gene knock-outs are not readily available
for most agricultural species, such as the chicken,
siRNA technology to reduce gene expression could
prove to be a powerful tool in advancing basic
knowledge of avian immune function and immune
responses to infection.
Our novel demonstration of siRNA-mediated knock-
down of iNOS mRNA and nitric oxide production in
HD11 macrophages enhances the validity and feasi-
bility of using RNAi technology in the avian immune
system and provides a foundation for future investiga-
tions in avian immune function and chicken immune
responses to disease (Benes et al., 2006).
Acknowledgements
The authors thank Natalie Smith (Iowa State
University) for her literature research and Pete Kaiser
(Institute for Animal Health, Compton, UK) for
information on quantitative real-time RT-PCR primers
and data analysis. This study was supported by the
Animal Health, Hatch Act, State of Iowa and Iowa State
University Center for Integrated Animal Genomics
Funds, National Research Initiative Grant no. 2004-
35205-14234 from the USDA Cooperative State
Research, Education, and Extension Service, and
Research Grant US-3408-03 from BARD, the Bina-
tional Agriculture Research and Development Fund.
References
Aktan, F., 2004. INOS-mediated nitric oxide production and its
regulation. Life Sci. 75, 639–653.
Alderton, W.K., Cooper, C.E., Knowles, R.G., 2001. Nitric oxide
synthases: structure, function, and inhibition. Biochem. J. 357,
593–615.
Babu, U.S., Gaines, D.W., Lillehoj, H.S., Raybourne, R.B., 2006.
Differential reactive oxygen and nitrogen production and clear-
ance of Salmonella serovars by chicken and mouse macrophages.
Dev. Comp. Immunol. 30, 942–953.
Benes, P., Maceckova, V., Zdrahal, Z., Konecna, H., Zahradnick, E.,
Muzik, J., Smarda, J., 2006. Role of vimentin in regulation of
moncyte/macrophage differentiation. Differentiation 74, 265–276.
J.H. Cheeseman et al. / Veterinary Immunology and Immunopathology 125 (2008) 375–380 379
Fig. 1. mRNA expression of iNOS, IFN-g, IL-1b, IL-6, TGF-b4, and SOCS-3 in HD-11 chicken macrophages treated with iNOS siRNAs and
stimulated with IFN-g. Reduction of iNOS mRNA expression in HD-11 chicken macrophages treated with iNOS siRNAs and IFN-g. Bars not
sharing a letter are significantly different by LS Means Student’s t-test (P = 0.03).
Beug, H., von Kirchbach, A., Doderlain, G., Conscience, J.F., Graf, T.,
1979. Chicken hematopoietic cells transformed by seven strains of
defective avian leukemia viruses display three distinct phenotypes
of differentiation. Cell 18, 375–390.
Blanchette, J., Jaramillo, M., Olivier, M., 2003. Signaling events
involved in interferon-g-inducible macrophage nitric oxide gen-
eration. Immunology 108, 513–522.
Bogdan, C., 2001. Nitric oxide and the immune response. Nat.
Immunol. 2, 907–916.
Bogdan, C., Rollinghoff, M., Diefenbach, A., 2000. The role of nitric
oxide in innate immunity. Immunol. Rev. 173, 17–26.
Chang, C.C., McCormick, C.C., Lin, A.W., Dietert, R.R., Sung, Y.J.,
1996. Inhibition of Nitric oxide synthase gene expression in vivo
and in vitro by repeated doses of endotoxin. Am. J. Physiol. 271,
G539–G548.
Cheeseman, J.H., Kaiser, M.G., Ciraci, C., Kaiser, P., Lamont, S.J.,
2007. Breed effect on early cytokine mRNA expression in spleen
and cecum of chickens with and without Salmonella enteritidis
infection. Dev. Comp. Immunol. 31, 52–60.
Chen, M., Granger, A.J., Vanbrocklin, M.W., Payne, W.S., Hunt, H.,
Zhang, H., Dodgson, J.B., Holmen, S.L., 2007. Inhibition of avian
leukosis virus replication by vector-based RNA interference.
Virology 365, 464–472.
Crippen, T.L., Sheffield, C.L., He, H., Lowry, V.K., Kogut, M.H.,
2003. Differential nitric oxide production by chicken immune
cells. Dev. Comp. Immunol. 27, 603–610.
Dai, F., Yusuf, F., Farjah, G.H., Brand-Saberi, B., 2005. RNAi-induced
targeted silencing of developmental control genes during chicken
embryogenesis. Dev. Biol. 285, 80–90.
Dil, N., Qureshi, M.A., 2003. Interleukin-1b does not contribute to
genetic strain-based differences in iNOS expression and activity in
chicken macrophages. Dev. Comp. Immunol. 27, 137–146.
Flandin, J.F., Chano, F., Descoteaux, A., 2006. RNA interference
reveals a role for TLR2 and TLR3 in the recognition of Leishma-
nia donovani promastigotes by interferon-g-primed macrophages.
Eur. J. Immunol. 36, 411–420.
Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok,
J.S., Tannenbaum, S.R., 1982. Analysis of nitrate, nitrite, and
[15N]nitrate in biological fluids. Anal. Biochem. 126, 131–138.
Hussain, I., Qureshi, M.A., 1997. Nitric oxide synthase activity and
mRNA expression in chicken macrophages. Poult. Sci. 76, 1524–
1530.
Jakowlew, S.B., Mathias, A., Lillehoj, H.S., 1997. Transforming
growth factor-b isoforms in the developing chicken intestine
and spleen: increase in transforming growth factor-b4 with
coccidian infection. Vet. Immunol. Immunopathol. 55, 321–
339.
Kleinert, H., Schwarz, P.M., Forstermann, U., 2003. Regulation of the
expression of inducible nitric oxide synthase. Biol. Chem. 384,
1343–1364.
Kleinert, H., Pautz, A., Linker, K., Schwarz, P.M., 2004. Regulation of
the expression of inducible nitric oxide synthase. Eur. J. Pharm.
500, 255–266.
Kogut, M.H., Rothwell, L., Kaiser, P., 2003. Differential regulation of
cytokine gene expression by avian heterophils during receptor-
mediated phagocytosis of opsonized and nonopsonized Salmo-
nella enteritidis. J. Interferon Cytokine Res. 23, 319–327.
Lillehoj, H.S., Li, G., 2004. Nitric oxide production by macrophages
stimulated with Coccidia sporozoites, Lipopolysaccharide, or
interferon-gamma, and it’s dynamic changes in SC and TK strains
of chickens infected withEimeria tenella. Avian Dis. 48, 244–253.
Liu, G., Ng, H., Akasaki, Y., Yuan, X., Ehtesham, M., Yin, D., Black,
K.L., Yu, J.S., 2004. Small interference RNA modulation of IL-10
in human monocyte-derived dendritic cells enhance the Th1
response. Eur. J. Immunol. 34, 1680–1687.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expres-
sion data using real-time quantitative PCR and the 2DDCT method.
Methods 25, 402–408.
MacMicking, J., Xie, Q., Nathan, C., 1997. Nitric oxide and macro-
phage function. Annu. Rev. Immunol. 15, 323–350.
McManus, M.T., Sharp, P.A., 2002. Gene silencing in mammals by
small interfering RNAs. Nat. Rev. Genet. 3, 737–747.
Okamura, M., Lillehoj, H.S., Raybourne, R.B., Babu, U.S., Heckert,
R.A., Tani, H., Sasai, K., Baba, E., Lillehoj, E.P., 2005. Differ-
ential responses of macrophages to Salmonella enterica serovars
enteritidis and typhimurium. Vet. Immunol. Immunopathol. 107,
327–335.
Paukku, K., Silvennoinen, O., 2004. STATs as critical mediators of
signal transduction and transcription: lessons learned from STAT5.
Cytokine Growth Factor Rev. 15, 5–455.
Pauls, E., Senserrich, J., Bofill, M., Clotet, B., Este, J.A., 2006.
Induction of interleukins IL-6 and IL-8 by siRNA. Clin. Exp.
Immunol. 147, 189–196.
Sato, F., Kurokawa, M., Yamauchi, N., Hattori, M.A., 2006. Gene
silencing of mysostatin in differentiation of chicken embryonic
myoblasts by small interfering RNA. Am. J. Physiol. Cell Physiol.
291, C538–545.
Schindler, H., Bogdan, C., 2001. NO as a signaling molecule; effects
on kinases. Internat. Immunopharmol. 1, 1443–1455.
SAS Institute. 2004. JMP statistics and grapics guide. Ver. 5.1.1., SAS
Institutue Inc., Car, N.C.
Sidahmed, A.M.E., Wilkie, B.N., 2007. Control of cytokine gene
expression using small RNA interference: blockade of interleukin-
10 and interferon-gamma gene expression in pigs. Vet. Immunol.
Immunopathol. 117, 86–94.
Song, K.D., Lillehoj, H.S., Choi, K.D., Zarlenga, D., Han, J.Y., 1997.
Expression and functional characterization of recombinant
chicken interferon-gamma. Vet. Immunol. Immunopathol. 58,
321–333.
Su, C.L., Austic, R.E., 1998. The utilization of dipeptides containing
L-arginine by chicken macrophages. Poult. Sci. 77, 1852–1857.
Sung, Y.J., Hotchkiss, J.H., Austic, R.E., Dietert, R.R., 1991. L-
Arginine-dependent production of a reactive nitrogen intermediate
by macrophages of a uricotelic species. J. Leuk. Biol. 50, 49–56.
Tan, J.C., Rabkin, R., 2005. Suppressors of cytokine signaling in
health and disease. Pediatr. Nephrol. 20, 567–575.
Tuschl, T., 2001. RNA interference and small interfering RNAs.
Chembiochemistry 2, 239–245.
Vodovotz, Y., 1997. Control of nitric oxide production by transforming
growth factor-b1: mechanistic insights and potential relevance to
human disease. Nitric Oxide: Biol. Chem. 1, 3–17.
Vodovotz, Y., Chester, L., Chong, H., Kim, S.J., Simpson, J.T.,
DeGraff, W., Cox, G.W., Roberts, A.B., Wink, D.A., Barcellos-
Hoff, M.H., 1999. Regulation of transforming growth factor b1 by
nitric oxide. Cancer Res. 59, 2142–2149.
Withanage, G.S.K., Mastroeni, P., Brooks, H.J., Maskell, D.J.,
McConnell, I., 2005. Oxidative and nitrosative responses of the
chicken macrophage cell line MQ-NCSU to experimental Salmo-
nella infection. Br. Poult. Sci. 46, 261–267.
Xing, Z., Schat, K.A., 2000. Expression of cytokine genes in Marek’s
disease virus-infected chickens and chicken embryo fibroblast
cultures. Immunology 100, 70–76.
J.H. Cheeseman et al. / Veterinary Immunology and Immunopathology 125 (2008) 375–380380
